Reserving full karyotyping for the 10% of fetuses with first trimester nuchal translucency (NT) measurements of 4 mm or more and using quantitative fluorescent polymerase chain reaction (qf-PCR) for less suspicious samples may be an effective screening strategy that provides rapid results at significant cost savings, according to a recent observational study.
Reserving full karyotyping for the 10% of fetuses with first trimester nuchal translucency (NT) measurements of 4 mm or more and using quantitative fluorescent polymerase chain reaction (qf-PCR) for less suspicious samples may be an effective screening strategy that provides rapid results at significant cost savings, according to a recent observational study.
Researchers from the United Kingdom evaluated approximately 17,500 chorionic villus samples obtained after assessing risk for trisomy 21 by measurement of fetal NT thickness at 11 to 13 weeks' gestation. They analyzed samples by full karyotyping and by qf-PCR for chromosomes 13, 18, 21, X, and Y.
They found the fetal karyotype to be normal in approximately 89% of cases and abnormal in the remaining 11%. The researchers calculated that while relying entirely on karyotyping reveals all clinically significant chromosomal abnormalities and relying entirely on qf-PCR identifies 97.9%, the combination strategy identifies 99% of significant abnormalities at 60% of the cost of full karyotyping for all.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More